Clinical trial

Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating…

NCT00068744 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated

Key facts

NCT number NCT00068744
Title Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
Official title Continuous Fluorouracil Plus Mitomycin C Versus Mitomycin C Plus Cisplatin As Chemotherapy Combination In Combined Radiochemotherapy For Locally Advanced Anal Cancer. A Phase II-III Study
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Terminated
Phase Phase 2/Phase 3
Study type Interventional
Conditions Anal Cancer
Intervention type Drug, Radiation
Interventions cisplatin, fluorouracil, mitomycin C, radiation therapy
Enrollment 88
Start date Jul 1, 2003
Primary completion Nov 1, 2007
First posted Sep 11, 2003
Last update posted Sep 24, 2012
Countries Belgium, Egypt, France, Germany, Italy, Netherlands, Serbia

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies